Skip to content
RushPR News – Lifestyle
Author:
Nuevocor
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
October 8, 2026